# Cardiac Imaging Modalities

> Cardiac imaging for NEET-SS Cardiology: choosing between echo, coronary CT, cardiac MRI and nuclear perfusion tests in exam-ready DM notes.

- Canonical URL: https://prepelephant.com/topics/neet-ss/cardiology/cardiac-imaging-modalities
- Exam / course: NEET-SS · Subject: Cardiology
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-02
- Last updated: 2026-10-02
- How to cite: "Cardiac Imaging Modalities", PrepElephant, https://prepelephant.com/topics/neet-ss/cardiology/cardiac-imaging-modalities

## Direct answer

Choosing the right cardiac imaging test is itself a favourite examination question. Echocardiography is the first-line test for structure and function. Coronary CT angiography is the preferred rule-out test for coronary disease in low-to-intermediate probability patients, with a high negative predictive value and CT-derived physiology as an adjunct. Stress imaging (stress echo, SPECT, PET or perfusion MRI) tests ischaemia in intermediate-to-high probability patients. Cardiac MRI is the tissue characteriser — for myocarditis, infiltration, viability and arrhythmogenic substrate — while nuclear bone-tracer scintigraphy diagnoses transthyretin amyloidosis. Invasive fractional flow reserve remains the reference standard for lesion significance.

## What you must remember

- **Echocardiography:** transthoracic study first for structure and function; transoesophageal for prosthetic valves, endocarditis, left atrial appendage thrombus and aortic disease; global longitudinal strain detects subclinical dysfunction — a meaningful fall during anthracycline or trastuzumab therapy prompts cardiology review.
- **Coronary CT angiography:** an anatomic test reported on the CAD-RADS scale; best for excluding disease in low-to-intermediate probability patients — a zero calcium score with a normal study carries an excellent prognosis; limited by heavy calcification, irregular rhythms and renal impairment.
- **Stress imaging:** stress echocardiography, SPECT or PET perfusion imaging and stress MRI detect flow-limiting stenosis; PET adds quantitative blood flow, exposing balanced three-vessel disease and microvascular dysfunction.
- **Cardiac MRI:** the gold standard for volumes and ejection fraction; late gadolinium enhancement separates ischaemic (subendocardial) from non-ischaemic (mid-wall, epicardial) disease; T1 mapping identifies amyloidosis (high values) and Anderson-Fabry disease (low); T2* quantifies iron; mapping criteria diagnose myocarditis; right ventricular findings support arrhythmogenic cardiomyopathy.
- **Viability testing:** the transmural extent of late gadolinium enhancement predicts recovery after revascularisation — segments with less than half-wall enhancement, stress-echo thinning or PET metabolic activity are viable.
- **Nuclear adjuncts:** technetium pyrophosphate or DPD scintigraphy with grade 2–3 uptake diagnoses transthyretin amyloidosis without biopsy in the right setting; FDG-PET supports cardiac sarcoidosis.
- **Radiation and availability logic:** echo and MRI are radiation-free; CT and nuclear studies carry dose — sequence tests sensibly and image before catheterising when non-obstructive disease is plausible.

## Common confusion

The recurring confusion is anatomic versus functional testing: CT angiography excludes plaque but does not prove its haemodynamic significance, whereas stress testing demonstrates ischaemia but not anatomy — hence "CT first in low probability, stress testing in intermediate-to-high". The second confusion is which test for which question: MRI for tissue, PET for perfusion and inflammation, bone scintigraphy for amyloid.

## Exam-focused takeaway

Stems ask "best next investigation": a young woman with atypical chest pain (coronary CT), new heart failure with a non-diagnostic echo (cardiac MRI), suspected amyloidosis with thick walls (bone scintigraphy plus MRI), or recurrent angina after bypass grafting. Learn each modality by its one irreplaceable strength.

## Frequently asked questions

### When is coronary CT angiography the test of choice?

In low-to-intermediate probability patients to rule out coronary disease, given its high negative predictive value — provided heart rate, rhythm and renal function permit a diagnostic study.

### What does cardiac MRI add over echocardiography?

Tissue characterisation — late gadolinium enhancement patterns, T1 and T2 mapping — identifying myocarditis, infiltration, iron, fibrosis and right ventricular substrate beyond what functional imaging shows.

### Which test diagnoses transthyretin cardiac amyloidosis non-invasively?

Grade 2–3 cardiac uptake on technetium pyrophosphate or DPD scintigraphy, in the right clinical setting and after excluding light-chain disease, avoids endomyocardial biopsy.

### Why can a normal perfusion scan miss three-vessel disease?

Balanced reduction of flow in all territories produces apparently uniform tracer uptake; quantitative PET myocardial blood flow uncovers the diffuse reduction.

### What defines lesion significance at catheterisation?

Fractional flow reserve of 0.80 or less (with hyperaemia) or instantaneous wave-free ratio of 0.89 or less — both identify stenoses that benefit from revascularisation.